Environmental Factors in the Epidemiology of Inflammatory Bowel Disease

Vatn, Morten H.

Pages 3-20

Role of the Intestinal Immune System in Health

Brandtzaeg, Per

Pages 23-56

Understanding the Epithelial Barrier in IBD

Odenwald, Matthew A. (et al.)

Pages 57-66

Intestinal Microbiology and Ecology in Crohn’s Disease and Ulcerative Colitis

Buttó, Ludovica F. (et al.)

Pages 67-74

The Immune System in IBD: Antimicrobial Peptides

Bevins, Charles L.

Pages 75-86

Vascular Responses to Intestinal Inflammation

Granger, D. Neil (et al.)

Pages 87-92

Immunobiology of Human Dendritic Cells in Inflammatory Bowel Disease

Baumgart, Daniel C.

Pages 93-100

Immunobiology of T-Cells in Inflammatory Bowel Disease

Snapper, S. (et al.)

Pages 101-109

Immunobiology of B Cells in Inflammatory Bowel Disease

Mizoguchi, Atsushi (et al.)

Pages 111-117

Immune Cells: Monocytes and Macrophages

Rogler, Gerhard

Pages 119-122

Immune Functions of Epithelial Cells in Inflammatory Bowel Disease

Campbell, Eric L. (et al.)

Pages 123-129

Autophagy and Endoplasmic Reticulum Stress

Kaser, Arthur

Pages 131-134

Matrix Metalloproteinases

Biancheri, Paolo (et al.)

Pages 135-140

Paradigm of T Cell Differentiation in IBD

Nagaishi, Takashi (et al.)

Pages 141-148

Mouse Models of Chronic Intestinal Inflammation: Characterization and Use in Pharmacological Intervention Studies

Webb, Cynthia Reinoso (et al.)

Pages 149-165

Stem Cells and Organoids to Study Epithelial Cell Biology in IBD

Múnera, Jorge O. (et al.)

Pages 167-172

Enhanced Endoscopy

Kiesslich, R.

Pages 175-183

Magnetic Resonance Enterography

Rogalla, Patrik (et al.)

Pages 185-203

Computed Tomography Enterography and Inflammatory Bowel Disease

Fletcher, J. G.

Pages 205-215

Ultrasound in Inflammatory Bowel Disease

Potthoff, A. (et al.)

Pages 217-231

Laboratory Evaluation, Including Novel Diagnostic Markers

Flamant, M. (et al.)

Pages 233-242

Pathology of Inflammatory Bowel Disease

Joseph, Nora E. (et al.)

Pages 243-258

Objective Assessment of Clinical Disease Activity

Louis, Edouard (et al.)

Pages 259-266

Objective Assessment of Endoscopic Disease Activity and Mucosal Healing

Christensen, Britt (et al.)

Pages 267-277

Evaluation of Quality of Life in Crohn’s Disease and Ulcerative Colitis: What Is Health-Related Quality of Life?

Carlsen, Katrine (et al.)

Pages 279-289

Evaluation of Health Economics in Inflammatory Bowel Disease

Khanna, Reena (et al.)

Pages 291-297

The Natural History of Inflammatory Bowel Disease

Bernstein, Charles N.

Pages 301-309

Conventional Medical Management of Crohn’s Disease: Sulfasalazine

Gassull, Miquel A. (et al.)

Pages 311-314

Steroid Therapy for Crohn’s Disease

Steinhart, A. Hillary

Pages 315-319

Thiopurines in Crohn’s Disease

Lahat, Adi (et al.)

Pages 321-331

Conventional Medical Management of Crohn’s Disease: Methotrexate

Harkin, Grace (et al.)

Pages 333-342

Adalimumab for the Treatment of Crohn’s Disease

Panaccione, Remo

Pages 343-349

Biologic Therapy of Crohn’s Disease: Certolizumab

Armuzzi, Alessandro (et al.)

Pages 351-356

Biologic Therapy for Crohn’s Disease: Infliximab

Klapproth, Jan-Michael A. (et al.)

Pages 357-365

Briakinumab and Ustekinumab: Anti-p40 Antibodies for Inflammatory Bowel Disease Treatment

Mannon, Peter

Pages 367-373

Biological Therapy of Crohn’s Disease: Natalizumab, Vedolizumab, and Anti-MadCAM

Hindryckx, Pieter (et al.)

Pages 375-380

Optimal Management of Fistulizing Crohn’s Disease

Peerani, Farhad (et al.)

Pages 381-386

Sulfasalazine and 5-Aminosalicylates for Ulcerative Colitis

Khanna, Reena (et al.)

Pages 389-397

Conventional Therapy of Ulcerative Colitis: Corticosteroids

Taylor, Kirstin (et al.)

Pages 399-412

Medical Management of Ulcerative Colitis: Conventional Therapy—Azathioprine

Levesque, Barrett G. (et al.)

Pages 413-419

Calcineurin Inhibitors in Ulcerative Colitis

Fischer, Andreas (et al.)

Pages 421-428

Biologic Therapy in Moderate-to-Severe Ulcerative Colitis: Infliximab

Lam, Mindy (et al.)

Pages 429-433

Biologic Therapy of Ulcerative Colitis: Adalimumab

Reinisch, Walter

Pages 435-439

Biologic Therapy of Ulcerative Colitis: Golimumab

Samaan, Mark A. (et al.)

Pages 441-448

Biologic Therapy of Ulcerative Colitis: Natalizumab, Vedolizumab, Etrolizumab (rHUMab Beta 7), Anti-MAdCAM

Vermeire, Severine

Pages 449-454

Probiotics, Prebiotics, and Antibiotics in IBD

Gionchetti, Paolo (et al.)

Pages 455-469

Biosimilars in the Treatment of Inflammatory Bowel Disease

Huang, Vivian W. (et al.)

Pages 471-479

Step-Up vs. Top-Down Approach in Crohn’s Disease

Yu, Christine Y. (et al.)

Pages 481-489

Leukocytapheresis Therapy of Inflammatory Bowel Disease

Kanai, Takanori

Pages 491-504

Surgical Management of Crohn’s Disease and Ulcerative Colitis

Cima, Robert R. (et al.)

Pages 505-517

Extraintestinal Manifestations: Autoimmune Hepatitis

Manns, Michael P. (et al.)

Pages 521-529

Primary Sclerosing Cholangitis

Chapman, Roger W. (et al.)

Pages 531-547

Autoimmune Pancreatitis and Other Organ Involvement

Kuwata, Go (et al.)

Pages 549-556

Cutaneous and Oral Manifestations of Inflammatory Bowel Disease

Allen, Caroline P. (et al.)

Pages 557-569

Arthritis, Arthropathy, and Osteoporosis in Inflammatory Bowel Disease

Tindell, Alistair (et al.)

Pages 571-583

Nutrition in Inflammatory Bowel Disease

Buchman, Alan L.

Pages 587-596

Pregnancy and Fertility in Inflammatory Bowel Disease

Matro, Rebecca (et al.)

Pages 599-607

Pediatric Aspects of Inflammatory Bowel Disease

Boyle, Brendan (et al.)

Pages 609-617

Management and Prevention of Infectious Diseases in IBD Patients

Macartney, Kristine (et al.)

Pages 621-638

Incidence of Cancer and Screening in Inflammatory Bowel Disease

Limdi, Jimmy K. (et al.)

Pages 639-652

Inflammatory Bowel Diseases: How to Identify High-Risk Patients

Cosnes, Jacques (et al.)

Pages 653-660

Patient Perspective on Inflammatory Bowel Disease

Williams, Ayesha (et al.)

Pages 663-665

Patient Resources in Inflammatory Bowel Disease

Lönnfors, Sanna (et al.)

Pages 667-672